Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC18A3 | Q16572 | 7/20 | 0.63 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.58 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.53 |
| ▸ | KMO | O15229 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclohexane SCHEMBL11811100 | 1.00 | SLC18A3 (0.63) | SLC18A3SIGMAR1CYP11B2CYP2D6KMO | |
| SCHEMBL30731352 | 1.00 | SLC18A3 (0.63) | SLC18A3SIGMAR1CYP11B2CYP2D6KMO | |
| SCHEMBL190370 | 1.00 | SLC18A3 (0.63) | SLC18A3SIGMAR1CYP11B2CYP2D6KMO | |
| Benzene SCHEMBL11808437 | 1.00 | SLC18A3 (0.63) | SLC18A3SIGMAR1CYP11B2CYP2D6KMO | |
| SCHEMBL11562787 | 1.00 | SLC18A3 (0.63) | SLC18A3SIGMAR1CYP11B2CYP2D6KMO | |
| SCHEMBL19198566 | 1.00 | SLC18A3 (0.63) | SLC18A3SIGMAR1CYP11B2CYP2D6KMO | |
| SCHEMBL790829 | 1.00 | SLC18A3 (0.63) | SLC18A3SIGMAR1CYP11B2CYP2D6KMO | |
| SCHEMBL42833 | 1.00 | SLC18A3 (0.63) | SLC18A3SIGMAR1CYP11B2CYP2D6KMO | |
| SCHEMBL19262690 | 1.00 | SLC18A3 (0.63) | SLC18A3SIGMAR1CYP11B2CYP2D6KMO | |
| Hydrogen Peroxide SCHEMBL11586135 | 0.97 | SLC18A3 (0.61) | SLC18A3SIGMAR1CYP11B2CYP2D6KMO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116102478-B | Preparation method of 1, 4-dicarbonyl thiosemicarbazide compound and anti-infection application | 中国医学科学院药物研究所 | 2025-04-15 | — | — | CN | claimed |
| CN-116102478-A | Preparation method of 1, 4-dicarbonyl thiosemicarbazide compound and anti-infection application | 中国医学科学院药物研究所 | 2023-05-12 | — | — | CN | claimed |
| CN-112094535-B | Ink formulation, photovoltaic device, and method of making the same | 纳晶科技股份有限公司 | 2022-09-09 | — | — | CN | claimed |
| CN-102908624-A | Pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoceptor agonist | ASTRAZENECA SWEDEN AB | 2013-02-06 | — | — | CN | claimed |
| CN-102088976-B | Comprising a muscarinic receptor antagonist and beta2-pharmaceutical products of adrenoreceptor agonists | ASTRAZENECA AB | 2012-12-26 | — | — | CN | claimed |
| CN-102131505-A | Pharmaceutical composition comprising a 4-hydroxy-2-oxo-2, 3- dihydro-1, 3-benzothiazol-7-yl compound for modulation of beta2-adrenoreceptor activity | ASTRAZENECA AB | 2011-07-20 | — | — | CN | claimed |
| CN-102088976-A | Comprising a muscarinic receptor antagonist and beta2-pharmaceutical products of adrenoreceptor agonists | ASTRAZENECA AB | 2011-06-08 | — | — | CN | claimed |
| US-7368203-B2 | Nonaqueous electrolyte secondary cell | SANYO ELECTRIC CO., LTD. (JP) | 2008-05-06 | — | — | US | claimed |
| EP-4543895-A1 | NOVEL IRON-BASED COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF, AND USE THEREOF AS CATALYSTS | Université Paris-Saclay (FR) | 2025-04-30 | — | — | EP | disclosed |
| CN-119816509-A | Novel iron-based compounds, method for the production thereof and use thereof as catalysts | 巴黎萨克雷大学 | 2025-04-11 | — | — | CN | disclosed |
| US-12076715-B1 | Synthesis and characterization of air-stable iron-based catalysts for Suzuki-Miyaura cross-coupling reactions of alkyl halides and aryl boronic esters | THE TRUSTEES OF BOSTON COLLEGE (MA) | 2024-09-03 | — | — | US | disclosed |
| CN-112812128-B | Macrocyclic compounds as ALK and ROS modulators | 正大天晴药业集团股份有限公司 | 2024-04-02 | — | — | CN | disclosed |
| WO-2024051631-A1 | MACROCYCLIC IMIDAZO[1,2-B]PYRIDAZINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 苏州朗睿生物医药有限公司 | 2024-03-14 | — | — | WO | disclosed |
| CN-117659043-A | Macrocyclic imidazo [1,2-b ] pyridazine derivative and preparation method and application thereof | 苏州朗睿生物医药有限公司 | 2024-03-08 | — | — | CN | disclosed |
| US-3981932-A | Ethynylbenzene compounds and derivatives thereof | WILLIAM H. RORER, INC. (US) | 1976-09-21 | — | — | US | disclosed |
| US-3980737-A | FIRE RETARDANTS, AGRICULTURAL CHEMICALS, FUEL ADDITIVES, PLASTICIZERS, INTERMEDIATES | ALELIO GAETANO F D | 1976-09-14 | — | — | US | disclosed |
| US-3966801-A | ANTIINFLAMMATORY AGENTS | WILLIAM H. RORER, INC. (US) | 1976-06-29 | — | — | US | disclosed |
| US-3952067-A | Ethynylbenzenes | WILLIAM H. RORER, INC. (US) | 1976-04-20 | — | — | US | disclosed |
| US-3950457-A | ADDITION POLYMERS OF UNSATURATED CARBOXYLATES | ALELIO GAETANO F D | 1976-04-13 | — | — | US | disclosed |
| US-3940434-A | ANTIINFLAMMATORY, ANALGESIC | CIBA-GEIGY CORPORATION (US) | 1976-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12076715-B1 | Synthesis and characterization of air-stable iron-based catalysts for Suzuki-Miyaura cross-coupling reactions of alkyl halides and aryl boronic esters | NBAS, BLVRB, TFRC | SLC18A3 2985/4885SIGMAR1 1965/4885CYP11B2 689/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.